Bicara Therapeutics (BCAX) Gains from Investment Securities (2024)
Bicara Therapeutics (BCAX) reported Gains from Investment Securities of $413000.0 for Q4 2024.
Bicara Therapeutics (BCAX) Gains from Investment Securities (2024) Analysis & Trends
Bicara Therapeutics has reported Gains from Investment Securities for 1 years, with the latest figure at $413000.0 in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities changed N/A year-over-year to $413000.0; the trailing twelve-month figure through Dec 2025 stood at $413000.0 (changed N/A YoY), and the FY2025 full-year result was $1.9 million, up 354.72% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at $413000.0.
- The five-year high for Gains from Investment Securities was $413000.0 in Q4 2024, with the low at $413000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Bicara Therapeutics | 1.31 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 413,000.00 |
| Dec 31, 2024 | 413,000.00 |